Europe — EMA

Onkotrone (Mitoxantrone)

Mitoxantrone, the active ingredient in Onkotrone, is an anthracycline antineoplastic agent presented as a sterile lyophilized powder for intravenous infusion use.

Mitoxantrone

Request sourcing

Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Onkotrone, is an anthracycline antineoplastic agent presented as a sterile lyophilized powder for intravenous infusion use. It is employed in the treatment of certain cancers and is administered under the supervision of oncologists. GNH USA supplies Onkotrone as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Mitoxantrone used for?

Mitoxantrone is used across several oncology‑ ... - Acute acute ?? ... .... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - .... ... - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →